Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn’s patients.

Baert F, Glorieus E, Reenaers C, D’Haens G, Peeters H, Franchimont D, Dewit O, Caenepeel P, Louis E, Van Assche G; BIRD (Belgian IBD Research and Development). J Crohns Colitis. 2013 Mar;7(2):154-60. doi: 10.1016/j.crohns.2012.03.018. Epub 2012 Apr 24

Voir l’article

← Retour aux publications